Terms: = Bone cancer AND XPA, XPAC, 7507, ENSG00000136936, XP1, P23025 AND Treatment
4 results:
1. Human in vitro skin organ culture as a model system for evaluating DNA repair.
Liu H; Tuchinda P; Fishelevich R; Harberts E; Gaspari AA
J Dermatol Sci; 2014 Jun; 74(3):236-41. PubMed ID: 24636351
[TBL] [Abstract] [Full Text] [Related]
2. Acute myeloid leukemia of donor origin after allogeneic stem cell transplantation from a sibling who harbors germline XPD and XRCC3 homozygous polymorphisms.
Diamond HR; Ornellas MH; Orfao A; Gomes BE; Campos MM; Fernandez TS; da Silva RI; Alves G; Lage C; da Silva DA; Moellmann-Coelho A; da Cruz GS; Bouzas LF; Abdelhay E
J Hematol Oncol; 2011 Sep; 4():39. PubMed ID: 21951951
[TBL] [Abstract] [Full Text] [Related]
3. xpa-210: a new proliferation marker to characterize tumor biology and progression of renal cell carcinoma.
Gakis G; Hennenlotter J; Scharpf M; Hevler J; Schilling D; Kuehs U; Stenzl A; Schwentner C
World J Urol; 2011 Dec; 29(6):801-6. PubMed ID: 21113600
[TBL] [Abstract] [Full Text] [Related]
4. Common variations in ERCC2 are associated with response to cisplatin chemotherapy and clinical outcome in osteosarcoma patients.
Caronia D; Patiño-García A; Milne RL; Zalacain-Díez M; Pita G; Alonso MR; Moreno LT; Sierrasesumaga-Ariznabarreta L; Benítez J; González-Neira A
Pharmacogenomics J; 2009 Oct; 9(5):347-53. PubMed ID: 19434073
[TBL] [Abstract] [Full Text] [Related]
